Kyverna Therapeutics Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Kyverna Therapeutics Inc
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
/ 
Frequently asked questions
To buy Kyverna Therapeutics Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Kyverna Therapeutics Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Kyverna Therapeutics Inc is KYTX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Kyverna Therapeutics Inc has its primary listing on NASDAQ. You can trade Kyverna Therapeutics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Kyverna Therapeutics Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Kyverna Therapeutics Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Kyverna Therapeutics Inc.